FLT3-IN-20

• UNSPSC Description:

  FLT3-IN-20 (compound 34f) is a potent FLT3 inhibitor with IC50 values of 1 and 4 nM for FLT3-D835Y and FLT3-ITD, respectively. FLT3-IN-20 has anti-proliferation efficacy in FLT3-ITD-positive AML cell lines MV4-11 and MOLM-13 (7 and 9 nM, respectively) and the MOLM-13 variant (4 nM) with the FLT3-ITD-D835Y mutation. FLT3-IN-20 can be used in research of cancer[1].

• Target Antigen:

  FLT3

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/flt3-in-20.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=S(C1=CC=C(NC2=CC(N[C@@H]3CC[C@@H](N)CC3)=NN4C2=NC=C4C5=CC=CC=C5)C=C1)(N6CCCC6)=O

• Molecular Weight:

  531.67

• References & Citations:

  [1]Břehová P, et, al. Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping. J Med Chem. 2023 Aug 24;66(16):11133-11157.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported